Home › Ulcerative Colitis › Pennsylvania
Ulcerative Colitis clinical trials in Pennsylvania
13 studies for Ulcerative Colitis are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Susquehanna Research Group, Harrisburg
- Penn State Milton S Hershey Medical Ctr, Hershey
- University of Pennsylvania, Philadelphia
- and 1 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Children's Hospital of Philadelphia (CHOP), Philadelphia
RecruitingPhase 3
Ages 2 to 19 · All sexes · Updated Sep 22, 2026 · NCT04844606A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- The Children's Hospital of Philadelphia /ID# 273222, Philadelphia
- Upmc Children'S Hospital Of Pittsburgh /ID# 272328, Pittsburgh
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Sep 22, 2026 · NCT07071519A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Allegheny Health Network, Wexford
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT06095128An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Penn State Milton S. Hershey Medical Center - Site Number: 8400066, Hershey
- University of Pennsylvania School of Medicine - Site Number: 8400072, Philadelphia
- The Allegheny Health Network (AHN) Center for Digestive Health - Site Number: 8400107, Pittsburgh
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Aug 20, 2026 · NCT07184996Inflammatory Bowel Disease (IBD) Research Registry
- University of Pittsburgh Medical Center, Pittsburgh
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT04243525BOOM-IBD2 Pivotal Clinical Trial
- Pennsylvania Hospital, Philadelphia
Recruiting
Ages 18 to 85 · All sexes · Updated Aug 6, 2026 · NCT06571669A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Penn State Health Milton South Hershey Medical Center, Hershey
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Jun 22, 2026 · NCT06405087A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400013, Harrisburg
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Apr 23, 2026 · NCT06975722Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
- UPMC Hillman Cancer Center, Pittsburgh
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT07223424Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Allegheny Health, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
Recruiting
Ages 18 to 85 · All sexes · Updated Jan 8, 2026 · NCT05987852From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.